Cim Has Boosted Biogen (BIIB) Stake; Ancora Advisors Lowered Lincoln Natl Ind (LNC) Position

July 17, 2017 - By Richard Conner

Ancora Advisors Llc decreased Lincoln Natl Corp Ind (LNC) stake by 50% reported in 2016Q4 SEC filing. Ancora Advisors Llc sold 5,000 shares as Lincoln Natl Corp Ind (LNC)’s stock declined 8.83%. The Ancora Advisors Llc holds 5,000 shares with $331,000 value, down from 10,000 last quarter. Lincoln Natl Corp Ind now has $15.90 billion valuation. The stock decreased 0.61% or $0.44 on July 14, reaching $71.34. About shares traded. Lincoln National Corporation (NYSE:LNC) has risen 47.27% since July 17, 2016 and is uptrending. It has outperformed by 30.57% the S&P500.

Cim Llc increased Biogen Inc (BIIB) stake by 4.94% reported in 2016Q4 SEC filing. Cim Llc acquired 1,383 shares as Biogen Inc (BIIB)’s stock declined 13.45%. The Cim Llc holds 29,367 shares with $8.33M value, up from 27,984 last quarter. Biogen Inc now has $60.09 billion valuation. The stock increased 0.88% or $2.45 on July 14, reaching $280.81. About shares traded. Biogen Inc (NASDAQ:BIIB) has risen 4.94% since July 17, 2016 and is uptrending. It has underperformed by 11.76% the S&P500.

Ancora Advisors Llc increased Costco Whsl Corp New (NASDAQ:COST) stake by 4,316 shares to 9,042 valued at $1.45 million in 2016Q4. It also upped Zoetis Inc (NYSE:ZTS) stake by 48,618 shares and now owns 59,968 shares. Express Scripts Hldg Co (NASDAQ:ESRX) was raised too.

Since February 7, 2017, it had 0 insider purchases, and 19 selling transactions for $45.02 million activity. Fuller Wilford H. also sold $163,417 worth of Lincoln National Corporation (NYSE:LNC) shares. $310,782 worth of Lincoln National Corporation (NYSE:LNC) shares were sold by Freitag Randal J. 2,275 shares valued at $163,421 were sold by Buckingham Lisa on Wednesday, February 22. $388,124 worth of stock was sold by TIDWELL ISAIAH on Friday, February 10. GLASS DENNIS R sold $3.47 million worth of stock or 47,995 shares. 2,275 shares were sold by Solon Kenneth S., worth $163,292 on Wednesday, February 22. MEE MICHAEL F had sold 30,173 shares worth $2.06 million.

Investors sentiment increased to 0.94 in 2016 Q4. Its up 0.12, from 0.82 in 2016Q3. It is positive, as 38 investors sold LNC shares while 223 reduced holdings. 97 funds opened positions while 149 raised stakes. 177.25 million shares or 1.59% more from 174.48 million shares in 2016Q3 were reported. Wells Fargo & Mn accumulated 1.52 million shares. Sg Americas Limited Com stated it has 0.03% in Lincoln National Corporation (NYSE:LNC). Ontario Teachers Pension Plan Board stated it has 28,791 shares. Bridgeway holds 0.72% of its portfolio in Lincoln National Corporation (NYSE:LNC) for 838,000 shares. Petrus Tru Co Lta has 0.05% invested in Lincoln National Corporation (NYSE:LNC). Suffolk Capital Mgmt Limited Com owns 0.08% invested in Lincoln National Corporation (NYSE:LNC) for 8,300 shares. First Republic Invest Mngmt Inc holds 0.09% in Lincoln National Corporation (NYSE:LNC) or 160,188 shares. Great West Life Assurance Can has 0.04% invested in Lincoln National Corporation (NYSE:LNC). Shell Asset reported 16,292 shares. Jennison Associates Lc holds 0% or 28,586 shares. Jacobs Levy Equity Mgmt invested 0.12% in Lincoln National Corporation (NYSE:LNC). Bradley Foster And Sargent Ct, a Connecticut-based fund reported 9,500 shares. Bluecrest Cap Management stated it has 98,070 shares or 0.36% of all its holdings. Brown Advisory has 0% invested in Lincoln National Corporation (NYSE:LNC). Delta Asset Management Llc Tn owns 0% invested in Lincoln National Corporation (NYSE:LNC) for 136 shares.

Analysts await Lincoln National Corporation (NYSE:LNC) to report earnings on August, 2 after the close. They expect $1.73 earnings per share, up 10.90% or $0.17 from last year’s $1.56 per share. LNC’s profit will be $385.58M for 10.31 P/E if the $1.73 EPS becomes a reality. After $1.92 actual earnings per share reported by Lincoln National Corporation for the previous quarter, Wall Street now forecasts -9.90% negative EPS growth.

Among 14 analysts covering Lincoln National (NYSE:LNC), 7 have Buy rating, 0 Sell and 7 Hold. Therefore 50% are positive. Lincoln National had 33 analyst reports since August 4, 2015 according to SRatingsIntel. The stock of Lincoln National Corporation (NYSE:LNC) earned “Overweight” rating by Morgan Stanley on Thursday, August 13. The firm has “Neutral” rating by Macquarie Research given on Thursday, April 14. The rating was maintained by RBC Capital Markets with “Sector Perform” on Thursday, February 4. The stock has “Hold” rating by Keefe Bruyette & Woods on Friday, June 23. The firm earned “Neutral” rating on Wednesday, April 6 by Citigroup. The rating was initiated by Citigroup on Thursday, January 26 with “Buy”. As per Friday, December 9, the company rating was upgraded by RBC Capital Markets. The firm has “Hold” rating given on Tuesday, August 4 by Zacks. The firm earned “Sector Perform” rating on Thursday, October 29 by RBC Capital Markets. The firm has “Overweight” rating given on Tuesday, September 29 by Piper Jaffray.

Among 23 analysts covering Biogen Idec Inc. (NASDAQ:BIIB), 14 have Buy rating, 0 Sell and 9 Hold. Therefore 61% are positive. Biogen Idec Inc. had 48 analyst reports since July 23, 2015 according to SRatingsIntel. Raymond James maintained the shares of BIIB in report on Tuesday, August 2 with “Strong Buy” rating. Leerink Swann downgraded the shares of BIIB in report on Thursday, March 16 to “Market Perform” rating. The firm earned “Overweight” rating on Wednesday, August 17 by Morgan Stanley. The rating was initiated by Citigroup with “Buy” on Thursday, February 25. The rating was downgraded by Citigroup on Tuesday, June 7 to “Neutral”. The stock of Biogen Inc (NASDAQ:BIIB) earned “Buy” rating by Jefferies on Wednesday, September 9. The firm has “Buy” rating given on Tuesday, August 25 by Cowen & Co. Standpoint Research initiated Biogen Inc (NASDAQ:BIIB) rating on Thursday, January 7. Standpoint Research has “Buy” rating and $360.0 target. The stock of Biogen Inc (NASDAQ:BIIB) earned “Hold” rating by Morgan Stanley on Wednesday, June 14. UBS upgraded the stock to “Neutral” rating in Monday, June 19 report.

Investors sentiment decreased to 0.92 in 2016 Q4. Its down 0.08, from 1 in 2016Q3. It dropped, as 90 investors sold BIIB shares while 341 reduced holdings. 93 funds opened positions while 304 raised stakes. 183.23 million shares or 1.51% less from 186.04 million shares in 2016Q3 were reported. Srb has 0.02% invested in Biogen Inc (NASDAQ:BIIB) for 538 shares. 3,729 were accumulated by Howard Hughes Institute. Ridgeworth Mgmt Llc stated it has 0.16% in Biogen Inc (NASDAQ:BIIB). Wealthtrust Axiom Ltd Llc has 920 shares for 0.09% of their portfolio. Point72 Asia (Hong Kong) Ltd holds 7,730 shares or 2.19% of its portfolio. Us Retail Bank De reported 128,919 shares or 0.13% of all its holdings. 40,737 are owned by Oxford Asset Mngmt. Hills Financial Bank And holds 4,564 shares or 0.45% of its portfolio. Sabby Mgmt Ltd Llc accumulated 20,000 shares. Rockefeller Service Inc, New York-based fund reported 229,435 shares. Spears Abacus Advisors Limited Liability Corp accumulated 7,115 shares. Sei Invs Com holds 291,519 shares. Fred Alger Mngmt owns 536,029 shares. Amica Pension Fund Board Of Trustees reported 8,280 shares. Sands Capital Mgmt Ltd Company reported 2.58 million shares stake.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.